MedPath

Hydroxyethyl Starch

Generic Name
Hydroxyethyl Starch
Brand Names
Hespan, Hextend, Volulyte, Voluven
Drug Type
Small Molecule
CAS Number
9005-27-0
Unique Ingredient Identifier
875Y4127EA

Overview

Hydroxyethyl starch (HES/HAES) is a nonionic starch derivative. Hydroxyethyl starches (HES) are synthetic colloids commonly used for fluid resuscitation to replace intravascular volume. HES is a general term and can be sub-classified according to average molecular weight, molar substitution, concentration, C2/C6 ratio and Maximum Daily Dose.

Background

Hydroxyethyl starch (HES/HAES) is a nonionic starch derivative. Hydroxyethyl starches (HES) are synthetic colloids commonly used for fluid resuscitation to replace intravascular volume. HES is a general term and can be sub-classified according to average molecular weight, molar substitution, concentration, C2/C6 ratio and Maximum Daily Dose.

Indication

An intravenous solution of hydroxyethyl starch is used to prevent shock following severe blood loss caused by trauma, surgery, or other issues.

Associated Conditions

  • Hypovolaemia

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2024/10/29
Phase 4
Not yet recruiting
Xiangya Hospital of Central South University
2022/07/27
Not Applicable
Recruiting
General Hospital of Ningxia Medical University
2022/07/27
Not Applicable
Completed
General Hospital of Ningxia Medical University
2020/09/28
N/A
Completed
The George Institute for Global Health, Australia
2018/09/19
Not Applicable
Completed
Holbaek Sygehus
2018/03/15
Early Phase 1
UNKNOWN
2017/11/22
Phase 4
Completed
2017/11/09
Phase 4
Completed
2017/10/11
Not Applicable
Completed
2017/09/11
Phase 4
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
HF Acquisition Co LLC, DBA HealthFirst
51662-1317
INTRAVENOUS
6 g in 100 mL
1/29/2024
Hospira, Inc.
0409-1555
INTRAVENOUS
6 g in 100 mL
2/15/2023
Hospira, Inc.
0409-7248
INTRAVENOUS
6 g in 100 mL
7/21/2022

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
VOLUVEN SOLUTION FOR INFUSION 6%
SIN12297P
INJECTION
60 g/l
5/16/2003

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Hydroxyethyl Starch 20 Sodium Chloride Injection
国药准字H20033771
化学药品
注射剂
7/23/2020
Hydroxyethyl Starch 20 Sodium Chloride Injection
国药准字H37023644
化学药品
注射剂
6/30/2020
Hydroxyethyl Starch 20 Sodium Chloride Injection
国药准字H20013073
化学药品
注射剂
6/30/2020
Hydroxyethyl Starch 20 Sodium Chloride Injection
国药准字H19999409
化学药品
注射剂
9/10/2020
Hydroxyethyl Starch 20 Sodium Chloride Injection
国药准字H20033770
化学药品
注射剂
7/23/2020
Hydroxyethyl Starch 20 Sodium Chloride Injection
国药准字H32020977
化学药品
注射剂
7/30/2020
Hydroxyethyl Starch 20 Sodium Chloride Injection
国药准字H62021260
化学药品
注射剂
11/17/2020
Hydroxyethyl Starch 130/0.4 and Electrolyte Injection
国药准字H20193403
化学药品
注射剂
12/26/2019
Hydroxyethyl Starch 130/0.4 and Electrolyte Injection
国药准字H20193404
化学药品
注射剂
12/26/2019
Hydroxyethyl Starch 130/0.4 and Electrolyte Injection
国药准字H20130006
化学药品
注射剂(大容量注射剂)
8/18/2022

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
VOLULYTE 6% SOLUTION FOR INFUSION
N/A
N/A
N/A
7/20/2009
© Copyright 2025. All Rights Reserved by MedPath